BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9606918)

  • 1. In vitro study of nicotine release from smokeless tobacco.
    Nasr MM; Reepmeyer JC; Tang Y
    J AOAC Int; 1998; 81(3):540-3. PubMed ID: 9606918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Five leading U.S. commercial brands of moist snuff in 1994: assessment of carcinogenic N-nitrosamines.
    Hoffmann D; Djordjevic MV; Fan J; Zang E; Glynn T; Connolly GN
    J Natl Cancer Inst; 1995 Dec; 87(24):1862-9. PubMed ID: 7494230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and pharmacodynamics of moist snuff in humans.
    Fant RV; Henningfield JE; Nelson RA; Pickworth WB
    Tob Control; 1999; 8(4):387-92. PubMed ID: 10629244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New and traditional smokeless tobacco: comparison of toxicant and carcinogen levels.
    Stepanov I; Jensen J; Hatsukami D; Hecht SS
    Nicotine Tob Res; 2008 Dec; 10(12):1773-82. PubMed ID: 19023828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential Application of USP Paddle and Basket Dissolution Methods in Discriminating for Portioned Moist Snuff and Snus Smokeless Tobacco Products.
    Rahman Z; Dharani S; Khuroo T; Khan MA
    AAPS PharmSciTech; 2021 Jan; 22(1):51. PubMed ID: 33459904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Method development and validation of dissolution testing for nicotine release from smokeless tobacco products using flow-through cell apparatus and UPLC-PDA.
    Miller JH; Danielson T; Pithawalla YB; Brown AP; Wilkinson C; Wagner K; Aldeek F
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Mar; 1141():122012. PubMed ID: 32065955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surveillance of moist snuff: total nicotine, moisture, pH, un-ionized nicotine, and tobacco-specific nitrosamines.
    Richter P; Hodge K; Stanfill S; Zhang L; Watson C
    Nicotine Tob Res; 2008 Nov; 10(11):1645-52. PubMed ID: 18988077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic absorption and effects of nicotine from smokeless tobacco.
    Benowitz NL
    Adv Dent Res; 1997 Sep; 11(3):336-41. PubMed ID: 9524434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relative buffering capacities of saliva and moist snuff: implications for nicotine absorption.
    Ciolino LA; McCauley HA; Fraser DB; Wolnik KA
    J Anal Toxicol; 2001; 25(1):15-25. PubMed ID: 11215994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surveillance of smokeless tobacco nicotine, pH, moisture, and unprotonated nicotine content.
    Richter P; Spierto FW
    Nicotine Tob Res; 2003 Dec; 5(6):885-9. PubMed ID: 14668072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing the nicotine content of smokeless tobacco products.
    Tilashalski K; Rodu B; Mayfield C
    J Am Dent Assoc; 1994 May; 125(5):590-2, 594. PubMed ID: 8195501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review of the evidence that pH is a determinant of nicotine dosage from oral use of smokeless tobacco.
    Tomar SL; Henningfield JE
    Tob Control; 1997; 6(3):219-25. PubMed ID: 9396107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral mucosal changes and nicotine disposition in users of Swedish smokeless tobacco products: a comparative study.
    Andersson G; Björnberg G; Curvall M
    J Oral Pathol Med; 1994 Apr; 23(4):161-7. PubMed ID: 8046653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of nicotine, pH, and moisture content of six U.S. commercial moist snuff products--Florida, January-February 1999.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1999 May; 48(19):398-401. PubMed ID: 10366135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brand specific responses to smokeless tobacco in a rat lip canal model.
    Schwartz JL; Brunnemann KD; Adami AJ; Panda S; Gordon SC; Hoffmann D; Adami GR
    J Oral Pathol Med; 2010 Jul; 39(6):453-9. PubMed ID: 20642753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pH of Smokeless Tobacco Determines Nicotine Buccal Absorption: Results of a Randomized Crossover Trial.
    Wilhelm J; Mishina E; Viray L; Paredes A; Pickworth WB
    Clin Pharmacol Ther; 2022 May; 111(5):1066-1074. PubMed ID: 34826137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversed phase ion-pair liquid chromatographic determination of nicotine in commercial tobacco products. 1. Moist snuff.
    Ciolino LA; McCauley HA; Fraser DB; Barnett DY; Yi TY; Turner JA
    J Agric Food Chem; 1999 Sep; 47(9):3706-12. PubMed ID: 10552709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular effects of buccal exposure to dermal nicotine patches in the dog: a comparative evaluation.
    Herman EH; Vick JA; Strong JM; Parker RJ; Geyer HM; Kramer ED; Higgins KM; Sistare FD
    J Toxicol Clin Toxicol; 2001; 39(2):135-42. PubMed ID: 11407499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical composition and carcinogenicity of smokeless tobacco.
    Hoffmann D; Djordjevic MV
    Adv Dent Res; 1997 Sep; 11(3):322-9. PubMed ID: 9524432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical profile of two types of oral snuff tobacco.
    Brunnemann KD; Qi J; Hoffmann D
    Food Chem Toxicol; 2002 Nov; 40(11):1699-703. PubMed ID: 12176096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.